Call Us: (937) 732-9273

Archive for the Medication Category

Details on Two Drug Trials for Borderline Personality Disorder

Details on Two Drug Trials for Borderline Personality Disorder

This follows a previous article with a general summary of the two medication studies for BPD presented here: http://pdan.org/drug-trials-encouraging-results-for-bpd/ SEROQUEL XR (OLANZAPINE) STUDY FOR BPD, 2010-2013 “Comparison of Low and Moderate Dosages of Extended- Release Quetiapine in Borderline Personality Disorder: A Randomized, Double-Blind, Placebo-Controlled Trial”, by Donald Black, Mary Zanarini, Ann […]

Read more

Drug Trials’ Encouraging Results for Borderline Personality Disorder

Borderline Personality Disorder (BPD) is a mental disorder that develops slowly, usually in adolescence and young adults and resolves slowly. After 4 years about 50 percent of BPD sufferers will remit, and after 10 years nearly 85 percent. When treated with empirically-validated treatments, these figures are considerably […]

Read more

OUR BLOG

ADDRESS

PDAN.org
1072 W Peachtree St NW #79468
Atlanta GA 30357
Phone: (209) 732-6001

Website: http://pdan.org
Email: info@pdan.org

DISCLAIMER

Important: This site has been provided for information purposes only and should not be considered a substitute for clinical therapy.

The opinions contained on this website remain those of the contributing authors.